Tandem Diabetes Care (TNDM) Net Margin Growth (1y) (2014 - 2026)
Tandem Diabetes Care (TNDM) Net Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | 656.00 |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -430.00 |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 201.00 |
| 10 | Tandem Diabetes Care | 1.16 Bn | 591.13 Mn | 136.79 Mn | 4,746.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,746.00 |
| Dec 31, 2025 | -45.00 |
| Sep 30, 2025 | 102.00 |
| Jun 30, 2025 | -790.00 |
| Mar 31, 2025 | -3,342.00 |
| Dec 31, 2024 | 1,549.00 |
| Sep 30, 2024 | 824.00 |
| Jun 30, 2024 | 436.00 |
| Mar 31, 2024 | 5,086.00 |
| Dec 31, 2023 | -802.00 |
| Sep 30, 2023 | 617.00 |
| Jun 30, 2023 | -1,073.00 |
| Mar 31, 2023 | -6,477.00 |
| Dec 31, 2022 | -1,233.00 |
| Sep 30, 2022 | -2,713.00 |
| Jun 30, 2022 | -984.00 |
| Mar 31, 2022 | -476.00 |
| Dec 31, 2021 | -500.00 |
| Sep 30, 2021 | 1,081.00 |
| Jun 30, 2021 | 2,907.00 |